|
LRMR Larimar Therapeutics Inc 1374690 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-29,613,000.00 |
| Balance Sheet |
|
Current Assets
|
$204,977,000.00 |
|
Assets
|
$208,511,000.00 |
|
Current Liabilities
|
$47,757,000.00 |
|
Liabilities
|
$50,478,000.00 |
|
Equity
|
$158,033,000.00 |
|
Shares Out
|
103882937.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-44,614,000.00 |
|
Investing Cash Flow
|
$29,000,000.00 |
| Market Analysis |
Market Cap
|
$397,871,648.71 |
|
Price
|
$3.83 |
|
BVPS
|
1.52 |
|
PB
|
2.52 |
|
EPS
|
-0.61 |
|
FCF
|
$-44,705,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:28 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
-0.73 |
|
|
2026-05-14 |
-0.31 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.41 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.61 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LRMR documents filed with the SEC.
LRMR Filings
Clear
